Rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations in the CYP24A1 gene
Rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations in the CYP24A1 gene
利福平可降低 CYP24A1 基因失活突变患者升高的血钙和尿钙水平
批准号：
350582
负责人：
Sochett Etienne B
金额：
$4.6万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-05-01 至 2018-05-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
High serum calcium levels are uncommon in children but important because they make the child ill and in the long-term can result in kidney stones. Recently, a change in one of the genes that breaks down the active form of vitamin D has been discovered in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文